{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:49:15Z","timestamp":1782730155371,"version":"3.54.5"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T00:00:00Z","timestamp":1778630400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T00:00:00Z","timestamp":1782691200000},"content-version":"vor","delay-in-days":47,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pulm Med"],"DOI":"10.1186\/s12890-026-04231-0","type":"journal-article","created":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:26:37Z","timestamp":1778675197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Remdesivir for the treatment of children hospitalized with COVID-19: a systematic review and meta-analysis"],"prefix":"10.1186","volume":"26","author":[{"given":"Shima","family":"Mahmoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Mohammadpour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrnaz","family":"Olfat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,13]]},"reference":[{"issue":"4","key":"4231_CR1","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bj.2020.04.007","volume":"43","author":"Y-C Liu","year":"2020","unstructured":"Liu Y-C, Kuo R-L, Shih S-R. COVID-19: The first documented coronavirus pandemic in history. Biomedical J. 2020;43(4):328\u201333.","journal-title":"Biomedical J"},{"issue":"Suppl 11","key":"4231_CR2","first-page":"e2020003","volume":"91","author":"S Manti","year":"2020","unstructured":"Manti S, Licari A, Montagna L, Votto M, Leonardi S, Brambilla I, Castagnoli R, Foiadelli T, Marseglia GL, Cardinale F. SARS-CoV-2 infection in pediatric population. Acta Bio Medica: Atenei Parmensis. 2020;91(Suppl 11):e2020003.","journal-title":"Acta Bio Medica: Atenei Parmensis"},{"issue":"12","key":"4231_CR3","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1097\/INF.0000000000004098","volume":"42","author":"AJ Tulling","year":"2023","unstructured":"Tulling AJ, Lugthart G, Mooij MG, Brackel CLH, Terheggen-Lagro SWJ, Oostenbrink R, Buysse CMP, Hashimoto S, Armbrust W, Bannier M, et al. Severe Pediatric COVID-19 and Multisystem Inflammatory Syndrome in Children From Wild-type to Population Immunity: A Prospective Multicenter Cohort Study With Real-time Reporting. Pediatr Infect Dis J. 2023;42(12):1077\u201385.","journal-title":"Pediatr Infect Dis J"},{"issue":"4","key":"4231_CR4","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1007\/s12519-023-00790-y","volume":"20","author":"Y-K Sun","year":"2024","unstructured":"Sun Y-K, Wang C, Lin P-Q, Hu L, Ye J, Gao Z-G, Lin R, Li H-M, Shu Q, Huang L-S. Severe pediatric COVID-19: A review from the clinical and immunopathophysiological perspectives. World J Pediatr. 2024;20(4):307\u201324.","journal-title":"World J Pediatr"},{"key":"4231_CR5","doi-asserted-by":"crossref","unstructured":"Esposito S, Marchetti F, Lanari M, Caramelli F, De Fanti A, Vergine G, Iughetti L, Fornaro M, Suppiej A, Zona S, et al. COVID-19 Management in the Pediatric Age: Consensus Document of the COVID-19 Working Group in Paediatrics of the Emilia-Romagna Region (RE-CO-Ped), Italy. Int J Environ Res Public Health. 2021;18(8):3919.","DOI":"10.3390\/ijerph18083919"},{"issue":"9","key":"4231_CR6","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.4103\/jfmpc.jfmpc_2583_20","volume":"10","author":"PK Panda","year":"2021","unstructured":"Panda PK, Sharawat IK, Natarajan V, Bhakat R, Panda P, Dawman L. COVID-19 treatment in children: a systematic review and meta-analysis. J family Med Prim care. 2021;10(9):3292\u2013302.","journal-title":"J family Med Prim care"},{"issue":"8","key":"4231_CR7","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1097\/INF.0000000000003576","volume":"41","author":"A Boast","year":"2022","unstructured":"Boast A, Curtis N, Holschier J, Purcell R, Bannister S, Plover C, Chinnapan M, Burgner D, Boyce SL, McNab S. An approach to the treatment of children with COVID-19. Pediatr Infect Dis J. 2022;41(8):654\u201362.","journal-title":"Pediatr Infect Dis J"},{"key":"4231_CR8","unstructured":"FDA approval for remdesivir in hopitalized patients with COVID-19. https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/214787Orig1s000lbl.pdf."},{"key":"4231_CR9","unstructured":"FDA approval. for remdesivir use in hospitalized pediatric patients less than 12 years of age weighing at least 3.5 kg, an Emergency Use Authorization. https:\/\/www.fda.gov\/media\/155772\/download."},{"issue":"5","key":"4231_CR10","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S2213-2600(22)00528-8","volume":"11","author":"A Amstutz","year":"2023","unstructured":"Amstutz A, Speich B, Mentr\u00e9 F, Rueegg CS, Belhadi D, Assoumou L, Burdet C, Murthy S, Dodd LE, Wang Y, et al. Effects of remdesivir in patients hospitalised with COVID-19: a systematic review and individual patient data meta-analysis of randomised controlled trials. Lancet Respir Med. 2023;11(5):453\u201364.","journal-title":"Lancet Respir Med"},{"issue":"1","key":"4231_CR11","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s15010-021-01671-0","volume":"50","author":"MT Angamo","year":"2022","unstructured":"Angamo MT, Mohammed MA, Peterson GM. Efficacy and safety of remdesivir in hospitalised COVID-19 patients: a systematic review and meta-analysis. Infection. 2022;50(1):27\u201341.","journal-title":"Infection"},{"issue":"1","key":"4231_CR12","doi-asserted-by":"publisher","first-page":"9622","DOI":"10.1038\/s41598-022-13680-6","volume":"12","author":"R Beckerman","year":"2022","unstructured":"Beckerman R, Gori A, Jeyakumar S, Malin JJ, Paredes R, P\u00f3voa P, Smith NJ, Teixeira-Pinto A. Remdesivir for the treatment of patients hospitalized with COVID-19 receiving supplemental oxygen: a targeted literature review and meta-analysis. Sci Rep. 2022;12(1):9622.","journal-title":"Sci Rep"},{"key":"4231_CR13","doi-asserted-by":"crossref","unstructured":"Ahmed A, Munoz FM, Muller WJ, Agwu A, Kimberlin DW, Galli L, Deville JG, Sue PK, Mendez-Echevarria A, Humeniuk R, et al. Remdesivir for COVID-19 in Hospitalized Children: A Phase 2\/3 Study. Pediatrics. 2024;153(3):e2023063775.","DOI":"10.1542\/peds.2023-063775"},{"issue":"1","key":"4231_CR14","doi-asserted-by":"publisher","first-page":"82","DOI":"10.2174\/2211352520666220517092803","volume":"21","author":"A Hormati","year":"2023","unstructured":"Hormati A, Ahmadpour S, Ghadir MR, Ghomi SYF, Tafaroji J, Movahedi Z, Hossaini SKE, Khoshgoftar M, Gheitani M. Comparison of Efficacy of Remdesivir with Supportive Care Alone in the Treatment of Critically Sick Adult and Child COVID-19 Patients: A Randomized Clinical Trial. Anti-Infective Agents. 2023;21(1):82\u20138.","journal-title":"Anti-Infective Agents"},{"key":"4231_CR15","unstructured":"IDSA Guidelines on the Treatment. and Management of Patients with COVID-19. https:\/\/www.idsociety.org\/COVID19guidelines#PediatricConsiderationsforTreatmentofSARS-CoV-2InfectionandMultisystemInflammatorySyndromeinChildren."},{"issue":"2","key":"4231_CR16","doi-asserted-by":"publisher","first-page":"e151","DOI":"10.15190\/d.2022.10","volume":"10","author":"A Chera","year":"2022","unstructured":"Chera A, Tanca A. Remdesivir: the first FDA-approved anti-COVID-19 treatment for young children. Discoveries. 2022;10(2):e151.","journal-title":"Discoveries"},{"key":"4231_CR17","doi-asserted-by":"publisher","first-page":"b2700","DOI":"10.1136\/bmj.b2700","volume":"339","author":"A Liberati","year":"2009","unstructured":"Liberati A, Altman DG, Tetzlaff J, Mulrow C, G\u00f8tzsche PC, Ioannidis JP, Clarke M, Devereaux PJ, Kleijnen J, Moher D. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration. BMJ. 2009;339:b2700.","journal-title":"BMJ"},{"key":"4231_CR18","volume-title":"The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for qualitative research","author":"JB Institute","year":"2017","unstructured":"Institute JB. The Joanna Briggs Institute critical appraisal tools for use in JBI systematic reviews: checklist for qualitative research. Adelaide: The Joanna Briggs Institute; 2017."},{"key":"4231_CR19","doi-asserted-by":"crossref","unstructured":"Sterne JA, Hern\u00e1n MA, Reeves BC, Savovi\u0107 J, Berkman ND, Viswanathan M, Henry D, Altman DG, Ansari MT, Boutron I. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.","DOI":"10.1136\/bmj.i4919"},{"issue":"5","key":"4231_CR20","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1016\/j.bja.2019.08.015","volume":"123","author":"A Granholm","year":"2019","unstructured":"Granholm A, Alhazzani W, M\u00f8ller MH. Use of the GRADE approach in systematic reviews and guidelines. Br J Anaesth. 2019;123(5):554\u20139.","journal-title":"Br J Anaesth"},{"issue":"3","key":"4231_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.3390\/life14030410","volume":"14","author":"M-E Cocuz","year":"2024","unstructured":"Cocuz M-E, Cocuz IG, Rodina L, Tataranu E, Caliman-Sturdza OA, Filip F. Treatment with Remdesivir of Children with SARS-CoV-2 Infection: Experience from a Clinical Hospital in Romania. Life. 2024;14(3):410.","journal-title":"Life"},{"key":"4231_CR22","doi-asserted-by":"crossref","unstructured":"Goldman DL, Aldrich ML, Hagmann SH, Bamford A, Camacho-Gonzalez A, Lapadula G, Lee P, Bonfanti P, Carter CC, Zhao Y. Compassionate use of remdesivir in children with severe COVID-19. Pediatrics. 2021;147(5):e2020047803.","DOI":"10.1542\/peds.2020-047803"},{"issue":"11","key":"4231_CR23","doi-asserted-by":"publisher","first-page":"e853","DOI":"10.1016\/j.clml.2021.07.025","volume":"21","author":"M Hammad","year":"2021","unstructured":"Hammad M, Shalaby L, Sidhom I, Sherief N, Abdo I, Soliman S, Madeny Y, Hassan R, Elmeniawy S, Khamis N. Management and outcome of coronavirus disease 2019 (COVID-19) in pediatric cancer patients: a single centre experience from a developing country. Clin Lymphoma Myeloma Leuk. 2021;21(11):e853\u201364.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"4231_CR24","doi-asserted-by":"crossref","unstructured":"Jugulete G, Luminos M, Pavelescu C, Meri\u0219escu MM. Remdesivir Efficacy and Tolerability in Children with COVID-19-Associated Allergic Comorbidities such as Asthma, Allergic Rhinitis, and Atopic Dermatitis. Child (Basel). 2023;10(5):810.","DOI":"10.3390\/children10050810"},{"issue":"2","key":"4231_CR25","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00431-023-05287-4","volume":"183","author":"K Kautsch","year":"2024","unstructured":"Kautsch K, Wi\u015bniowska J, Friedman-Gruszczy\u0144ska J, Buda P. Evaluation of the safety profile and therapeutic efficacy of remdesivir in children with SARS-CoV-2 infection - a single-center, retrospective, cohort study. Eur J Pediatr. 2024;183(2):591\u20138.","journal-title":"Eur J Pediatr"},{"key":"4231_CR26","doi-asserted-by":"crossref","unstructured":"Khalil A, Mohamed A, Hassan M, Magboul S, Ali H, Elmasoudi AS, Ellithy K, Qusad M, Alhothi A, Al Maslamani E. Efficacy and Safety of Remdesivir in Hospitalized Pediatric COVID-19: A Retrospective Case-Controlled Study. Ther Clin Risk Manag 2023:19:949\u201358.","DOI":"10.2147\/TCRM.S432565"},{"issue":"12","key":"4231_CR27","doi-asserted-by":"publisher","first-page":"1853","DOI":"10.1248\/bpb.b22-00470","volume":"45","author":"S Manabe","year":"2022","unstructured":"Manabe S, Mizuno S, Jinda T, Kasai M. Safety of Remdesivir in 20 Children with COVID-19-Case Series. Biol Pharm Bull. 2022;45(12):1853\u20136.","journal-title":"Biol Pharm Bull"},{"key":"4231_CR28","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1007\/s00431-020-03876-1","volume":"180","author":"A M\u00e9ndez-Echevarr\u00eda","year":"2021","unstructured":"M\u00e9ndez-Echevarr\u00eda A, P\u00e9rez-Mart\u00ednez A, Gonzalez del Valle L, Ara MF, Melendo S, Ruiz de Valbuena M, Vazquez-Martinez JL, Morales-Mart\u00ednez A, Remesal A, S\u00e1ndor-Bajusz KA. Compassionate use of remdesivir in children with COVID-19. Eur J Pediatrics. 2021;180:1317\u201322.","journal-title":"Eur J Pediatrics"},{"issue":"1","key":"4231_CR29","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1080\/0284186X.2023.2169079","volume":"62","author":"RYL Ong","year":"2023","unstructured":"Ong RYL, Seah VXF, Chong CY, Thoon KC, Tan NWH, Li J, Nadua KD, Soh SY, Seng MS-F, Pham TNA. A cohort study of COVID-19 infection in pediatric oncology patients plus the utility and safety of remdesivir treatment. Acta Oncol. 2023;62(1):53\u20137.","journal-title":"Acta Oncol"},{"issue":"1","key":"4231_CR30","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13052-024-01606-z","volume":"50","author":"L Romani","year":"2024","unstructured":"Romani L, Roversi M, Bernardi S, Venturini E, Garazzino S, Don\u00e0 D, Krzysztofiak A, Montagnani C, Funiciello E. Cal\u00f2 Carducci FI: Use of Remdesivir in children with COVID-19: report of an Italian multicenter study. Ital J Pediatr. 2024;50(1):32.","journal-title":"Ital J Pediatr"},{"issue":"4","key":"4231_CR31","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/INF.0000000000003814","volume":"42","author":"AM Samuel","year":"2023","unstructured":"Samuel AM, Hacker LL, Zebracki J, Bogenschutz MC, Schulz L, Strayer J, Vanderloo JP, Cengiz P, Henderson S. Remdesivir use in pediatric patients for SARS-CoV-2 treatment: single academic center study. Pediatr Infect Dis J. 2023;42(4):310\u20134.","journal-title":"Pediatr Infect Dis J"},{"issue":"1","key":"4231_CR32","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40348-024-00175-9","volume":"11","author":"A Schulz","year":"2024","unstructured":"Schulz A, Huynh N, Heger M, Bakir M. Adverse effects of remdesivir for the treatment of acute COVID-19 in the pediatric population: a retrospective observational study. Mol Cell Pediatr. 2024;11(1):2.","journal-title":"Mol Cell Pediatr"},{"issue":"12","key":"4231_CR33","doi-asserted-by":"publisher","first-page":"e1698","DOI":"10.1002\/hsr2.1698","volume":"6","author":"VXF Seah","year":"2023","unstructured":"Seah VXF, Ong RYL, Kam KQ, Thoon KC, Tan NWH, Li J, Nadua KD, Chong CY, Yung CF. Remdesivir therapy for severe pediatric COVID-19 in Singapore: A single-center retrospective observational cohort study. Health Sci Rep. 2023;6(12):e1698.","journal-title":"Health Sci Rep"},{"issue":"9","key":"4231_CR34","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1016\/j.jiac.2023.06.006","volume":"29","author":"K Shoji","year":"2023","unstructured":"Shoji K, Asai Y, Akiyama T, Tsuzuki S, Matsunaga N, Suzuki S, Iwamoto N, Funaki T, Miyairi I, Ohmagari N. Clinical efficacy of remdesivir for COVID-19 in children: A propensity-score-matched analysis. J Infect Chemother. 2023;29(9):930\u20133.","journal-title":"J Infect Chemother"},{"issue":"11","key":"4231_CR35","doi-asserted-by":"publisher","first-page":"e0241827","DOI":"10.1371\/journal.pone.0241827","volume":"15","author":"I Lakbar","year":"2020","unstructured":"Lakbar I, Luque-Paz D, Mege J-L, Einav S, Leone M. COVID-19 gender susceptibility and outcomes: A systematic review. PLoS ONE. 2020;15(11):e0241827.","journal-title":"PLoS ONE"},{"issue":"S3","key":"4231_CR36","first-page":"e2022195","volume":"93","author":"I Brambilla","year":"2022","unstructured":"Brambilla I, Delle Cave F, Guarracino C, De Filippo M, Votto M, Licari A, Pistone C, Tondina E. Obesity and COVID-19 in children and adolescents: a double pandemic. Acta Biomed. 2022;93(S3):e2022195.","journal-title":"Acta Biomed"},{"issue":"1","key":"4231_CR37","doi-asserted-by":"publisher","first-page":"2232818","DOI":"10.1080\/07853890.2023.2232818","volume":"55","author":"KH Nguyen","year":"2023","unstructured":"Nguyen KH, Levisohn A, McChesney C, Vasudevan L, Bednarczyk RA, Corlin L. Disparities in child and adolescent COVID-19 vaccination coverage and parental intent toward vaccinations for their children and adolescents. Ann Med. 2023;55(1):2232818.","journal-title":"Ann Med"},{"key":"4231_CR38","doi-asserted-by":"publisher","first-page":"321","DOI":"10.2147\/JEP.S484596","volume":"16","author":"IR Latarissa","year":"2024","unstructured":"Latarissa IR, Rendrayani F, Iftinan GN, Suhandi C, Meiliana A, Sormin IP, Barliana MI, Lestari K. The Efficacy of Oral\/Intravenous Corticosteroid Use in COVID-19 Patients: A Systematic Review. J Exp Pharmacol. 2024;16:321\u201337.","journal-title":"J Exp Pharmacol"},{"key":"4231_CR39","doi-asserted-by":"crossref","unstructured":"Nieves DJ, Tran MT, Singh J, Ashouri N, Morphew T, Lusk JG, Adler-Shohet FC, Marano R, Osborne S, Strickland J et al. Remdesivir Use in Pediatric Patients with Acute SARS-CoV-2 Infection Is Safe and Well Tolerated. Child (Basel) 2025, 12(3).","DOI":"10.3390\/children12030331"},{"issue":"1","key":"4231_CR40","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1080\/17512433.2021.1856655","volume":"14","author":"J Charan","year":"2021","unstructured":"Charan J, Kaur RJ, Bhardwaj P, Haque M, Sharma P, Misra S, Godman B. Rapid review of suspected adverse drug events due to remdesivir in the WHO database; findings and implications. Expert Rev Clin Pharmacol. 2021;14(1):95\u2013103.","journal-title":"Expert Rev Clin Pharmacol"},{"issue":"4","key":"4231_CR41","doi-asserted-by":"publisher","first-page":"463","DOI":"10.23736\/S0026-4806.22.08035-1","volume":"114","author":"G Adamo","year":"2023","unstructured":"Adamo G, Amata M, Cannizzaro N, Chessari C, Sapienza GM, Capizzi GM, Battaglia S, Benfante A, Scichilone N. Transient asymptomatic bradycardia and remdesivir in COVID-19 patients. Minerva Med. 2023;114(4):463\u20138.","journal-title":"Minerva Med"},{"issue":"9","key":"4231_CR42","doi-asserted-by":"publisher","first-page":"e356","DOI":"10.1097\/INF.0000000000003214","volume":"40","author":"I Eleftheriou","year":"2021","unstructured":"Eleftheriou I, Liaska M, Krepis P, Dasoula F, Dimopoulou D, Spyridis N, Tsolia M. Sinus Bradycardia in Children Treated With Remdesivir for COVID-19. Pediatr Infect Dis J. 2021;40(9):e356.","journal-title":"Pediatr Infect Dis J"},{"issue":"5","key":"4231_CR43","doi-asserted-by":"publisher","first-page":"e068564","DOI":"10.1136\/bmjopen-2022-068564","volume":"13","author":"E Tian","year":"2023","unstructured":"Tian E, Cosme C, Bauzon J, Batra K, Azar F, Schreiber A. Remdesivir-associated bradycardia in COVID-19: a rapid review protocol. BMJ Open. 2023;13(5):e068564.","journal-title":"BMJ Open"},{"issue":"7","key":"4231_CR44","doi-asserted-by":"publisher","first-page":"E242","DOI":"10.1503\/cmaj.211698","volume":"194","author":"K Ali","year":"2022","unstructured":"Ali K, Azher T, Baqi M, Binnie A, Borgia S, Carrier FM, Cavayas YA, Chagnon N, Cheng MP, Conly J, et al. Remdesivir for the treatment of patients in hospital with COVID-19 in Canada: a randomized controlled trial. CMAJ. 2022;194(7):E242\u201351.","journal-title":"CMAJ"},{"issue":"5","key":"4231_CR45","doi-asserted-by":"publisher","first-page":"1172","DOI":"10.1093\/cid\/ciae333","volume":"79","author":"ME Sise","year":"2024","unstructured":"Sise ME, Santos JR, Goldman JD, Tuttle KR, Teixeira JP, Seibert AF, Koullias Y, Llewellyn J, Regan S, Zhao Y, et al. Efficacy and Safety of Remdesivir in People With Impaired Kidney Function Hospitalized for COVID-19 Pneumonia: A Randomized Clinical Trial. Clin Infect Dis. 2024;79(5):1172\u201381.","journal-title":"Clin Infect Dis"}],"container-title":["BMC Pulmonary Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12890-026-04231-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04231-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12890-026-04231-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T10:33:37Z","timestamp":1782729217000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12890-026-04231-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,13]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4231"],"URL":"https:\/\/doi.org\/10.1186\/s12890-026-04231-0","relation":{},"ISSN":["1471-2466"],"issn-type":[{"value":"1471-2466","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,13]]},"assertion":[{"value":"7 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declration"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"286"}}